MELISSA D SELKE

Allopathic & Osteopathic Physicians|Family Medicine HILLSBOROUGH, NJ NPI 1669488367

General Payments — all program years on this page

$2,133.25

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 144
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $245.66 across 15 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $245.6615

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Novo Nordisk AS $94.146
Acerta Pharma LLC $44.073
PFIZER INC. $31.072
ABBVIE INC. $24.651
Astellas Pharma US Inc $22.641
Merck Sharp & Dohme Corporation $15.731
Lilly USA, LLC $13.361

By program year

Program yearAmountRecords
2018 $540.3938
2019 $701.4149
2020 $143.077
2021 $96.737
2022 $245.4618
2023 $160.5310
2024 $245.6615

Records — PY2024 (15)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1096590149 Novo Nordisk Inc $14.57 07/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096679901 Novo Nordisk Inc $13.66 03/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096917528 Novo Nordisk Inc $14.08 07/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096999742 Novo Nordisk Inc $21.63 01/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097110585 Novo Nordisk Inc $14.14 08/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097789028 Novo Nordisk Inc $16.06 11/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104414945 AstraZeneca Pharmaceuticals LP $14.61 09/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105633784 AstraZeneca Pharmaceuticals LP $16.29 05/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105829541 AstraZeneca Pharmaceuticals LP $13.17 08/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106054036 ABBVIE INC. $24.65 07/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131323436 PFIZER INC. $15.20 04/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131767128 PFIZER INC. $15.87 07/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135210756 Lilly USA, LLC $13.36 06/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139422689 Astellas Pharma US Inc $22.64 10/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141982515 Merck Sharp & Dohme LLC $15.73 08/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.